Solarea Bio, a US-based clinical-stage biotech company, is pioneering a new approach to bone health management with the beta launch of Bondia. The company is dedicated to leveraging microbial diversity to develop innovative solutions for managing inflammatory diseases. Through its consumer health brand, Journa, the company aims to improve human wellbeing with clinically tested and naturally formulated medical food products. Bondia, a…
Wile, a startup specializing in women’s health supplements targeting perimenopause and midlife hormonal shifts, has been acquired by Nameless CPG, an Austin-based company. While specific financial terms were not disclosed, it was confirmed that investors in Wile would receive a stake in Nameless CPG as part of the acquisition. Prior to the acquisition, Wile secured $3 million in pre-seed funding, supported by…
Midi Health, a virtual healthcare provider for perimenopause and menopause, has successfully raised $60 million in a Series B funding round. This latest injection of capital, led by Emerson Collective, raises the company’s total funding to an impressive $100 million. Additional investors include GV (Google Ventures), who led the previous funding round, along with Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel…
Healthcare company Included Health has unveiled its latest innovation: the Specialty Care Clinic. This novel clinic model aims to swiftly connect individuals with expert medical opinions, primary care, mental health support, and navigation services, specifically targeting specialty care needs, including menopause-related health concerns. The San Francisco-based company has identified a critical gap in the healthcare landscape concerning specialty care access, particularly for…
Seed Health has launched CODA, a computational biology platform aimed at discovering and developing precision probiotics and microbiome-directed interventions. Powered by the Human Phenotype Project, the world’s most extensive multi-omics dataset, CODA focuses on advancing research in metabolic health, brain health, menopause, and longevity. CODA integrates over three million phenotypic data points from more than 13,000 individuals across 40,000 cumulative subject years.…
Midi Health, a virtual care clinic specializing in women’s health during perimenopause and menopause, has teamed up with Cleo, a global caregiving platform, to provide comprehensive support for women facing hormonal changes. The collaboration aims to address the specific healthcare needs of women during this critical phase of their lives. The partnership between Midi Health and Cleo allows for personalized guidance and…
Bayer has announced positive topline results from the Phase III OASIS 3 study, shedding light on the potential efficacy and safety of their investigational compound, elinzanetant, in treating moderate to severe vasomotor symptoms (VMS) linked to menopause. These findings bolster the case for elinzanetant’s marketing authorization submissions, which Bayer plans to present to health authorities. In the OASIS 3 study, elinzanetant demonstrated…
SRI (formerly Stanford Research Institute) and Lisa Health, the company behing the Midday menopause app, recently published a study shedding light on the often-overlooked challenges faced by menopausal women in the workforce. The study, conducted across the United States with 351 working women aged 40–65, aimed to understand the intersection of menopause and professional life. “There is a notable gap between desired…